| Everest Organics Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524790 |
NSE Symbol : - |
P/E(TTM) : - |
|
ISIN Demat : INE334C01029 |
Div & Yield% : - |
EPS(TTM) : - |
|
Book Value(₹) : 50.61 |
Market Cap(₹Cr) : 216.28 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 44.05 | 32.45 | 52.62 | 52.51 | 49.45 | 42.67 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 44.05 | 32.45 | 52.62 | 52.51 | 49.45 | 42.67 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.14 | 0.33 | 0.30 | 0.13 | 0.24 | 0.22 |
| Total Income | 44.19 | 32.77 | 52.91 | 52.64 | 49.69 | 42.89 |
| Total Expenditure | 40.62 | 36.10 | 49.66 | 49.71 | 46.74 | 40.15 |
| PBIDT | 3.57 | -3.33 | 3.26 | 2.93 | 2.95 | 2.74 |
| Interest | 1.35 | 1.29 | 1.24 | 1.45 | 1.49 | 1.29 |
| PBDT | 2.22 | -4.62 | 2.01 | 1.48 | 1.46 | 1.45 |
| Depreciation | 1.47 | 1.47 | 1.85 | 1.33 | 1.32 | 1.29 |
| Tax | 0.00 | 0.00 | 0.03 | 0.02 | 0.01 | 0.04 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.01 | 0.00 | 0.07 | 0.12 | 0.10 | 0.08 |
| Reported Profit After Tax | 0.74 | -6.09 | 0.06 | 0.02 | 0.03 | 0.04 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.74 | -6.09 | 0.06 | 0.02 | 0.03 | 0.04 |
| EPS (Unit Curr.) | 0.93 | -7.61 | 0.07 | 0.02 | 0.04 | 0.04 |
| EPS (Adj) (Unit Curr.) | 0.93 | -7.61 | 0.07 | 0.02 | 0.04 | 0.04 |
| Calculated EPS (Unit Curr.) | 0.93 | -7.61 | 0.07 | 0.02 | 0.04 | 0.04 |
| Calculated EPS (Adj) (Unit Curr.) | 0.93 | -7.61 | 0.07 | 0.02 | 0.04 | 0.04 |
| Calculated EPS (Ann.) (Unit Curr.) | 3.70 | -30.45 | 0.29 | 0.08 | 0.15 | 0.18 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 3.70 | -30.45 | 0.29 | 0.08 | 0.15 | 0.18 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 |
| Reserve & Surplus | 32.49 | 31.75 | 37.84 | 38.28 | 38.28 | 38.25 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 8.10 | -10.26 | 6.20 | 5.58 | 5.97 | 6.42 |
| PBDTM(%) | 5.04 | -14.24 | 3.82 | 2.82 | 2.95 | 3.40 |
| PATM(%) | 1.68 | -18.77 | 0.11 | 0.04 | 0.06 | 0.09 |